ATE466023T1 - Mannose-spezifische adhesinen und deren vervendung - Google Patents

Mannose-spezifische adhesinen und deren vervendung

Info

Publication number
ATE466023T1
ATE466023T1 AT05722070T AT05722070T ATE466023T1 AT E466023 T1 ATE466023 T1 AT E466023T1 AT 05722070 T AT05722070 T AT 05722070T AT 05722070 T AT05722070 T AT 05722070T AT E466023 T1 ATE466023 T1 AT E466023T1
Authority
AT
Austria
Prior art keywords
mannose
adhesins
specific
specific adhesins
variants
Prior art date
Application number
AT05722070T
Other languages
English (en)
Inventor
Gabriele Pretzer
Johannes Snel
Peter Bron
Vos Willem De
Michiel Kleerebezem
Original Assignee
Friesland Brands Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friesland Brands Bv filed Critical Friesland Brands Bv
Application granted granted Critical
Publication of ATE466023T1 publication Critical patent/ATE466023T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05722070T 2004-03-23 2005-03-22 Mannose-spezifische adhesinen und deren vervendung ATE466023T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04075945 2004-03-23
PCT/NL2005/000216 WO2005090396A1 (en) 2004-03-23 2005-03-22 Novel mannose-specific adhesins and their use

Publications (1)

Publication Number Publication Date
ATE466023T1 true ATE466023T1 (de) 2010-05-15

Family

ID=34928124

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05722070T ATE466023T1 (de) 2004-03-23 2005-03-22 Mannose-spezifische adhesinen und deren vervendung

Country Status (6)

Country Link
US (1) US20090214476A1 (de)
EP (1) EP1730179B1 (de)
JP (1) JP2007530034A (de)
AT (1) ATE466023T1 (de)
DE (1) DE602005020915D1 (de)
WO (1) WO2005090396A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2832443C (en) * 2011-04-06 2020-08-25 The Board Of Regents Of The University Of Texas System Modulating bacterial mam polypeptides in pathogenic disease
EP3512872A1 (de) * 2016-09-13 2019-07-24 Intrexon Actobiotics NV Mukoadhäsiver mikroorganismus
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501056D0 (sv) * 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli

Also Published As

Publication number Publication date
DE602005020915D1 (de) 2010-06-10
WO2005090396A1 (en) 2005-09-29
US20090214476A1 (en) 2009-08-27
JP2007530034A (ja) 2007-11-01
EP1730179A1 (de) 2006-12-13
EP1730179B1 (de) 2010-04-28

Similar Documents

Publication Publication Date Title
ATE474585T1 (de) Probiotische enterokokken für eine verbesserte immunität
UA101301C2 (ru) ВЫДЕЛЕННОЕ АНТИТЕЛО ПРОТИВ IL-23pl 9 И ЕГО ПРИМЕНЕНИЕ
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
DE602005012276D1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
WO2008036932A3 (en) Compositions and methods comprising boswellia species
ATE548381T1 (de) Modifizierte erythropoietin (epo)-polypeptide mit erhöhter proteaseresistenz und pharmazeutische zusammensetzungen daraus
EP4477742A3 (de) Gereinigte zusammensetzungen aus mesenchymalen stammzellen und verfahren zur reinigung von zusammensetzungen aus mesenchymalen stammzellen
BR112012017345A2 (pt) "composições e métodos de pgl para a produção aumentada de isopreno e outros produtos com 6-fosfogliconolactonase (pgl)"
ATE536376T1 (de) Humanes bindungsmolekül gegen cd1a
WO2008108830A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
MX2009005849A (es) Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas.
WO2005060707A3 (en) Methods of use of probiotic lactobacilli for companion animals
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
Shi et al. A clinic trial evaluating the effects of aloe vera fermentation gel on recurrent aphthous stomatitis
EP2481814A3 (de) Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Krebs
GB0418388D0 (en) Cell therapy
BRPI0407176B8 (pt) composições compreendendo uma ou mais cepas de bifidobacterium e seus usos
WO2008091873A3 (en) Compositions and methods for the identification, assessment, prevention and therapy of thymic lymphoma or hamartomatous tumours
DE602005020915D1 (de) Mannose-spezifische adhesinen und deren vervendung
ATE524488T1 (de) Lysobactinamide
TW200745132A (en) Novel, acyclically substituted furopyrimidine derivatives and use thereof
WO2005021575A3 (en) Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
WO2007084488A3 (en) Adam10 and its uses related to infection
TW200724679A (en) Treatment of disease using an improved regulated expression system

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties